Assignment problem:
1. Disorder: Define and describe the clinical schizophrenia symptoms that manifest with this disorder (DSM-5 Definition)
2. Etiology of the disorder: Describe the known and potential contributing factors of this disorder, your discussion must include the proposed neurological and biochemical underpinnings of the disorder (although these may be theoretical). Your discussion must include both genetic and epigenetic variables. Environmental & sociocultural factors relevant to the disorder (e.g., increased incidence rate, etc.) must be included in your discussion.
3. Treatment- Part 1: Describe what evidence-based research has shown to be the most effective psychopharmacologic intervention for this disorder and discuss any controversies in psychopharmacology which may influence the pharmacologic treatment of this disorder.
4. Treatment- Part 2: Describe what evidence-based research has been shown to be the most effective psychotherapeutic intervention for this disorder.
5. Research gaps: Illustrate an advanced understanding of the biological underpinnings and psychopharmacologic approaches to the treatment of this disorder by discussing gaps in what is known about the disorder and psychopharmacologic treatment of this disorder and future directions for science. Additional research may help you to identify clinical trials currently in progress to address the psychopharmacologic treatment of this disorder.